Glaucoma Progression and Development Following Secondary Intraocular Lens Surgery.

IF 1.1 4区医学 Q4 OPHTHALMOLOGY

Ophthalmic surgery, lasers & imaging retina Pub Date : 2026-10-01 Epub Date: 2026-09-30 DOI:10.3928/23258160-20260819-03

B Michelle Kim, Kenny Y Wang, Mohamad Rani Hassoun, Kannan Sharma, Matthew R Starr

{"title":"Glaucoma Progression and Development Following Secondary Intraocular Lens Surgery.","authors":"B Michelle Kim, Kenny Y Wang, Mohamad Rani Hassoun, Kannan Sharma, Matthew R Starr","doi":"10.3928/23258160-20260819-03","DOIUrl":null,"url":null,"abstract":"Background and objective: This study aimed to investigate glaucoma progression following secondary intraocular lens (SIOL) implantation by surgical approach.Patients and methods: This was a single-center retrospective study of 440 eyes that received SIOL implantation, including scleral-sutured, scleral-fixated, anterior chamber, and sulcus-fixated. Glaucoma progression was defined as new diagnosis, procedure for intraocular pressure (IOP) control, or IOP elevation ≥ 24 mmHg or ≥ 5 mmHg above baseline requiring additional medications. Risk factors were assessed using multivariable analysis.Results: Mean age at surgery was 71.3 years and 29.3% of patients had prior glaucoma. Overall, 33.2% developed glaucoma progression. Prior glaucoma (hazard ratio 2.08 [95% CI 1.47-2.94], P < .001) and cystoid macular edema (1.63 [1.06-2.52], P = .026) were associated with glaucoma progression on multivariable analysis. There was no difference in glaucoma progression between scleral-sutured, scleral-fixated, anterior chamber, or sulcus-fixated implantation techniques.Conclusion: Our results suggest that surgeons should use their preferred SIOL implantation technique but closely monitor postoperative IOP.","PeriodicalId":19679,"journal":{"name":"Ophthalmic surgery, lasers & imaging retina","volume":" ","pages":"634-641"},"PeriodicalIF":1.1000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic surgery, lasers & imaging retina","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3928/23258160-20260819-03","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background and objective: This study aimed to investigate glaucoma progression following secondary intraocular lens (SIOL) implantation by surgical approach.

Patients and methods: This was a single-center retrospective study of 440 eyes that received SIOL implantation, including scleral-sutured, scleral-fixated, anterior chamber, and sulcus-fixated. Glaucoma progression was defined as new diagnosis, procedure for intraocular pressure (IOP) control, or IOP elevation ≥ 24 mmHg or ≥ 5 mmHg above baseline requiring additional medications. Risk factors were assessed using multivariable analysis.

Results: Mean age at surgery was 71.3 years and 29.3% of patients had prior glaucoma. Overall, 33.2% developed glaucoma progression. Prior glaucoma (hazard ratio 2.08 [95% CI 1.47-2.94], P < .001) and cystoid macular edema (1.63 [1.06-2.52], P = .026) were associated with glaucoma progression on multivariable analysis. There was no difference in glaucoma progression between scleral-sutured, scleral-fixated, anterior chamber, or sulcus-fixated implantation techniques.

Conclusion: Our results suggest that surgeons should use their preferred SIOL implantation technique but closely monitor postoperative IOP.

查看原文本刊更多论文

二次人工晶状体手术后青光眼的进展和发展。

背景与目的：本研究旨在探讨继发性人工晶状体植入术后青光眼的进展情况。患者和方法：这是一项单中心回顾性研究，440只眼睛接受了SIOL植入术，包括巩膜缝合、巩膜固定、前房和沟固定。青光眼进展被定义为新诊断，眼压（IOP）控制程序，或IOP升高≥24 mmHg或≥5 mmHg高于基线需要额外药物。采用多变量分析评估危险因素。结果：平均手术年龄为71.3岁，29.3%的患者既往有青光眼。总体而言，33.2%的患者发生青光眼进展。多变量分析显示，既往青光眼（风险比2.08 [95% CI 1.47-2.94], P < .001）和囊状黄斑水肿（风险比1.63 [1.06-2.52],P = .026）与青光眼进展相关。巩膜缝合、巩膜固定、前房或沟固定植入技术在青光眼进展方面没有差异。结论：我们的结果提示外科医生应采用他们首选的SIOL植入技术，并密切监测术后IOP。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ophthalmic surgery, lasers & imaging retina OPHTHALMOLOGY-SURGERY

CiteScore

1.80

自引率

0.00%

发文量

期刊介绍： OSLI Retina focuses exclusively on retinal diseases, surgery and pharmacotherapy. OSLI Retina will offer an expedited submission to publication effort of peer-reviewed clinical science and case report articles. The front of the journal offers practical clinical and practice management features and columns specific to retina specialists. In sum, readers will find important peer-reviewed retina articles and the latest findings in techniques and science, as well as informative business and practice management features in one journal.